EP1200014A2 - Nitinol a proprietes multiples obtenu par traitement thermique - Google Patents

Nitinol a proprietes multiples obtenu par traitement thermique

Info

Publication number
EP1200014A2
EP1200014A2 EP00941621A EP00941621A EP1200014A2 EP 1200014 A2 EP1200014 A2 EP 1200014A2 EP 00941621 A EP00941621 A EP 00941621A EP 00941621 A EP00941621 A EP 00941621A EP 1200014 A2 EP1200014 A2 EP 1200014A2
Authority
EP
European Patent Office
Prior art keywords
stent
shape
guidewire
cells
memory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP00941621A
Other languages
German (de)
English (en)
Other versions
EP1200014B1 (fr
Inventor
Steven Walak
Paul Dicarlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Boston Scientific Corp
Original Assignee
Boston Scientific Ltd Barbados
Boston Scientific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Ltd Barbados, Boston Scientific Corp filed Critical Boston Scientific Ltd Barbados
Publication of EP1200014A2 publication Critical patent/EP1200014A2/fr
Application granted granted Critical
Publication of EP1200014B1 publication Critical patent/EP1200014B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/0105Open ended, i.e. legs gathered only at one side
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/016Filters implantable into blood vessels made from wire-like elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/008Quadric-shaped paraboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0042Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in shape-memory transition temperatures, e.g. in martensitic transition temperature, in austenitic transition temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0048Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability

Definitions

  • the present invention is related to the use of shape memory materials in medical devices.
  • a shape memory material can assume an initial high temperature configuration and a deformed low temperature configuration and revert back to the initial high temperature configuration upon the application of heat.
  • the high temperature configuration of the material is set into the material or memorized during an initial shaping step in which the material is maintained at a high temperature in a desired shape for a period of time.
  • This shape memory exhibited by metals results from the metal undergoing a reversible solid state phase transition. Specifically, the metal transitions from an austenitic state to a martensitic state with a decrease in temperature.
  • the temperature at which the transition begins is typically designated M s (martensite start temperature) while the temperature at which the transition finishes is designated M f (martensite finish temperature).
  • M s martensite start temperature
  • M f martensite finish temperature
  • a s Austenitic start temperature
  • a f Austenitic finish temperature
  • Nitinol stents which are fully expanded in the austenitic state and compressed or partially expanded in the martensitic state have been disclosed.
  • the specific Nitinol alloy is chosen such that the stent will be in the austenitic state at body temperature.
  • the stent Prior to insertion into the body, the stent is maintained at low temperature corresponding to a temperature within the martensitic range.
  • the stent is warmed to at least the A f temperature and in the process expanded to its desired final diameter.
  • Shape-memory metals have been disclosed for use in other medical devices as well.
  • the present invention is directed to medical devices which use shape- memory materials that have been differentially heat treated to exhibit spatially varying properties such as elasticity and stiffness.
  • the present invention is directed to medical devices having been formed, at least in part, from shape-memory materials which have been locally treated to alter their memory characteristics relative to portions of the device which have not been subjected to the local heat treatment. Specifically, a region of the shape-memory material is treated to decrease the stiffness of the region relative to the remainder of the medical device. Desirably, the local treatment will destroy the superelastic properties of the locally treated region.
  • the invention is directed in particular to a stent having been formed at least in part of a shape-memory material.
  • the stent comprises a plurality of cells arranged in columns extending from one end of the stent to the other. Adjacent columns of cells are interconnected.
  • the stent includes at least one differently treated column of cells which has been treated differently from the remainder of the stent to have different shape-memory properties from the remainder of the stent.
  • the invention is also directed to a stent wherein at least one of the columns is characterized by a reduced elasticity relative to the remainder of the columns.
  • the invention is also directed to a stent wherein at least one of the columns is characterized by a reduced stiffness relative to the remainder of the columns.
  • the invention is further directed to a stent wherein at a desired temperature range, at least one longitudinal column of cells does not have superelastic properties while the remainder of the longitudinal columns do have superelastic properties.
  • the invention is also directed to a stent having been formed of a shape memory material and comprising a plurality of spaced segments with adjacent spaced segments connected to each other by one or more connector sections.
  • Each segment comprises a series of interconnected cells.
  • the cells in plan view are of polygonal configuration.
  • the segments have a reduced stiffness relative to the connector sections.
  • the segments are not superelastic.
  • the invention is directed to a medical guidewire having been formed at least in part of a shape-memory metal. Different portions of the shape-memory metal have been treated differently to have different shape-memory properties.
  • the guidewire is subjected to a local heat treatment resulting in a reduced stiffness compared with the remainder of the guidewire.
  • a guidewire of desired flexibility can be prepared.
  • the invention is directed to implantable medical filters such as vena cava filter having been formed of shape-memory materials. At least a portion of the shape-memory material is differently treated to alter the shape- memory properties of the material relative to the untreated shape-memory material. Desirably, the differently treated portion will be heat treated and exhibit a greater tendency toward plastic deformation relative to the remainder of the filter.
  • Figure 4a is a side elevational view of a stent made in accordance with the present invention.
  • Figure 4b is a side elevational view of the stent of Fig. 4a after it has been bent.
  • Figures 5 a and 5 b are views of embodiments of the invention in which connecting segments have been treated.
  • Fig. 6a shows a side elevational view of an inventive guidewire.
  • Fig. 6b shows the guidewire of Fig. 6a in a bent configuration.
  • Fig. 6c shows the guidewire of Fig. 6b after it has been released from the bent configuration.
  • Fig. 6d shows a side elevational view of an inventive guidewire whose distal tip has been treated to exhibit a reduced stiffness.
  • Fig. 7a shows a side elevational view of a prior art guidewire.
  • Fig. 7b shows the guidewire of Fig. 7a in a bent configuration.
  • Fig. 8 shows a side elevational view of an inventive vena cava filter.
  • the present invention is directed to the selective treatment of portions of a medical device containing a shape memory material. More specifically, the invention is directed to differential treatment of the shape memory material in a medical device to achieve different physical properties in different portions of the device.
  • Medical devices made of a shape memory material such as Nitinol typically have shape memory characteristics. The shape memory characteristics of the material may be altered by heat treating the material.
  • By locally treating portions of a shape-memory metal it is possible to produce a metal with spatial variations in the elasticity and stiffness of the metal. The locally treated portions will initiate plastic deformation at a lower strain than the portions that have not been locally treated.
  • the material may simply have a reduced stiffness in the locally treated portion or the superelasticity of the locally treated portion may be destroyed with the locally treated portion being plastically deformable.
  • a stress-strain curve (solid line) is shown for a shape-memory material.
  • the stress-strain curve (dashed line) for the same material following additional heat treatment of the material is also shown.
  • the material has a reduced load and unload plateau, as shown in Fig. 1 and the material initiates plastic deformation at a lower strain level.
  • the shape memory material based medical device is typically subject to a first annealing using standard annealing processing conditions as are known in the art. Desirably, the device will be annealed for about 5 minutes to about 40 minutes at a temperature ranging from about 400 C to about 575 C. More desirably, the device will be annealed for about 10 minutes to about 15 minutes. Also more desirably, the device will be annealed at a temperature ranging from about 450 C to about 550 C. Shorter or longer periods may be used as may higher or lower temperatures, depending on the material being annealed and the desired properties of the material.
  • Another suitable method involves applying a heated inert gas jet to a desired portion of the medical device to selectively heat a desired portion of the device.
  • Yet another method involves the use of an induction coil.
  • An induction coil may be placed over a desired portion of the medical device to effect induction heating of the desired portion of the medical device.
  • a laser may also be used to selectively heat desired regions of the medical device.
  • the desired regions of the medical device may -7- also be brazed.
  • the medical device may also be placed in a heat treating fluid such as a salt bath or a fluidized sand bath with appropriate sections of the device insulated.
  • the second annealing step is typically carried out at a temperature of about 550 C to about 600 C for about five minutes to about 20 minutes. At such temperatures, the stiffness of the material will be reduced. As with the first annealing step, the exact time and temperature of the second annealing step depends on the material chosen (i.e. its composition) and on the form of the material (for example, in wire form or in sheet form). In certain cases, it may be desirable for the second annealing step to be carried out over shorter or longer periods of time and at lower or higher temperatures than those disclosed above.
  • the invention contemplates localized heat treating of a variety of medical devices including stents, medical guidewires and filters such as vena cava filters.
  • stents include a variety of related devices including stents, grafts and stent-grafts in particular and endoluminal prostheses in general.
  • the invention is directed to a stent, shown generally at 100, comprised of a plurality of cells 104 arranged in columns 108 extending from one end 112 of the stent to the other end 116. Adjacent columns 108 of cells 104 are interconnected.
  • the stent includes at least one differently treated column 108a of cells 104a which has been treated differently from the remainder of columns 108b to have different shape-memory properties from the remainder of the stent.
  • differently treated column 108a will be characterized by an increased tendency to plastic deformation relative to the remainder of the stent and will be plastically deformable. More desirably, the superelasticity of the differently treated portion will be destroyed as a result of the heat treatment.
  • the invention also contemplates treating the column(s) such that the treated portion loses its shape memory characteristic.
  • Fig. 3b shows the stent of Fig. 3a in a partially expanded state.
  • Untreated columns 108b are shown in an expanded state, having been exposed to a sufficient temperature to cause the metal to transition to its austenitic state.
  • Treated column 108a is in an unexpanded state, the superelastic properties of the material having been locally destroyed.
  • the stent may later be 'touched up' via mechanical expansion of the cells of the treated column to better fit in a lumen.
  • the invention is also directed to the stent shown generally at 100 in Fig. 5a, comprised of a plurality of spaced segments 120.
  • Each segment 120 is desirably comprised of a series of interconnected cells 124.
  • cells 124 will be of polygonal configuration in plan view. More desirably, they will be hexagonal.
  • Adjacent spaced segments 120 are connected to each other by one or more connector sections 128.
  • Connector sections 128 may be disposed at an oblique angle relative to the longitudinal axis 180 of the stent as shown in Fig. 5a or they may be substantially parallel to the longitudinal axis 180 as shown in Fig. 5b. They may be straight or curved.
  • Segments 120 have been subjected to a local heat treatment, in accordance with the invention. Desirably, segments 120 will be of lower stiffness than connector sections 128 as a result of the heat treatment.
  • Stent 100 may be made of any suitable shape-memory material including shape-memory metals such as Nitinol. Nitinol with a composition of about 55.75% (by weight) nickel and 44.25% (by weight) titanium may be particularly well suited for use in the present invention.
  • the stent may be made of shape-memory wire or a sheet or tube of shape-memory material.
  • the invention is also directed to stents similar to those shown in Figs. 5a and 5b, such as those disclosed in US 08/942162 incorporated herein in its entirety by reference, wherein the connector sections and the segments are subject to different heat treatments.
  • stent configurations of Figs. 3-5 are intended to be exemplary. Stents with other designs may be treated similarly.
  • the invention is directed to medical guide wires made of shape-memory materials, portions of which have been differentially treated.
  • a medical guidewire such as that shown at 200 in Fig. 6a, is specially treated toward distal end 204 of the guidewire.
  • Region 208 of the device is heat treated to increase the tendency toward plastic deformation of the treated portion relative to the remainder of the guidewire. This, in turn, allows the guidewire to have a region of greater flexibility and a region of reduced flexibility corresponding to the locally treated section of the guidewire.
  • Figs. 6b and Fig. 6c illustrate the guidewire of Fig. 6a as it is bent and released.
  • guidewire 200 is bent.
  • Region 208 has a greater tendency toward plastic deformation.
  • the remainder 212 of guidewire 200 is in the austenitic state and thus deforms elastically.
  • the guidewire of Fig. 6b is shown in Fig. 6c after it has been released from its bent position.
  • Locally treated region 208 remains bent while austenitic regions 212 recovery fully to their configuration prior to being bent.
  • Nitinol which has been treated to have spatially varying properties, it is possible to prepare a guidewire which may be permanently deformed within the body.
  • a local heat treatment may also be used to reduce the stiffness of the tip of the guidewire prior to inserting the guidewire into the body. This is illustrated schematically in Fig. 6d. Distal end 204 of guidewire 200 has been subject to an additional heat treatment to reduce the stiffness of the distal end relative to the remainder of the guidewire. If the superelasticity is completely destroyed, a permanent bend may be placed in the guidewire, thereby allowing a physician to shape a guide wire as desired.
  • a fully austenitic guidewire is shown in various states in Figs. 7a-c.
  • Fig. 7a shows guidewire 200.
  • the entire guidewire is in the austenitic state 212.
  • guidewire 200 is shown in a bent configuration.
  • a small region 208 is in a stress-induced martensitic state while the remainder 212 of guidewire 200 is in the austenitic phase.
  • the entire guidewire Upon release of the guidewire, as shown in Fig. 7c, the entire guidewire returns to the configuration it had prior to being bent.
  • the entire guidewire is in the austenitic state.
  • the invention is directed to medical filters made, at least in part, of differentially treated shape-memory materials.
  • Fig. 8 shows a vena cava filter generally at 300.
  • Vena cava filter 300 is similar in design to that disclosed in commonly assigned US Patent 5,709,704 to Nott et al., the content of which is incorporated herein in its entirety by reference.
  • Filter 300 is constructed, at least in part, of a shape memory material.
  • Filter 300 includes a single cell 304 in which the shape-memory material is differentially heat treated to increase the tendency to plastic deformation of the desired portion of the filter.
  • binary shape-memory metals such as Nitinol or other alloys of Nickel and Titanium will be used.
  • the invention also contemplates the use of doped binary metals as well. Suitable dopants include Chromium, Niobium and Vanadium. Additional suitable shape-memory alloys are disclosed in WO 95/31945, the contents of which are incorporated herein in their entirety by reference.

Landscapes

  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Prostheses (AREA)
EP00941621A 1999-07-28 2000-06-22 Nitinol a proprietes multiples obtenu par traitement thermique Expired - Lifetime EP1200014B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/362,261 US6485507B1 (en) 1999-07-28 1999-07-28 Multi-property nitinol by heat treatment
US362261 1999-07-28
PCT/US2000/017116 WO2001008600A2 (fr) 1999-07-28 2000-06-22 Nitinol a proprietes multiples obtenu par traitement thermique

Publications (2)

Publication Number Publication Date
EP1200014A2 true EP1200014A2 (fr) 2002-05-02
EP1200014B1 EP1200014B1 (fr) 2006-10-18

Family

ID=23425389

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00941621A Expired - Lifetime EP1200014B1 (fr) 1999-07-28 2000-06-22 Nitinol a proprietes multiples obtenu par traitement thermique

Country Status (9)

Country Link
US (3) US6485507B1 (fr)
EP (1) EP1200014B1 (fr)
JP (1) JP2003505194A (fr)
AT (1) ATE342699T1 (fr)
AU (1) AU5630900A (fr)
CA (1) CA2378920C (fr)
DE (1) DE60031413T2 (fr)
IL (1) IL147727A0 (fr)
WO (1) WO2001008600A2 (fr)

Families Citing this family (161)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485507B1 (en) 1999-07-28 2002-11-26 Scimed Life Systems Multi-property nitinol by heat treatment
US6890350B1 (en) 1999-07-28 2005-05-10 Scimed Life Systems, Inc. Combination self-expandable, balloon-expandable endoluminal device
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US6402771B1 (en) 1999-12-23 2002-06-11 Guidant Endovascular Solutions Snare
US6575997B1 (en) 1999-12-23 2003-06-10 Endovascular Technologies, Inc. Embolic basket
US6660021B1 (en) 1999-12-23 2003-12-09 Advanced Cardiovascular Systems, Inc. Intravascular device and system
US7918820B2 (en) 1999-12-30 2011-04-05 Advanced Cardiovascular Systems, Inc. Device for, and method of, blocking emboli in vessels such as blood arteries
US6540722B1 (en) 1999-12-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US6695813B1 (en) 1999-12-30 2004-02-24 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US7632303B1 (en) 2000-06-07 2009-12-15 Advanced Cardiovascular Systems, Inc. Variable stiffness medical devices
US6652576B1 (en) * 2000-06-07 2003-11-25 Advanced Cardiovascular Systems, Inc. Variable stiffness stent
US6964670B1 (en) 2000-07-13 2005-11-15 Advanced Cardiovascular Systems, Inc. Embolic protection guide wire
US7101391B2 (en) * 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US7402173B2 (en) * 2000-09-18 2008-07-22 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication
US6537294B1 (en) 2000-10-17 2003-03-25 Advanced Cardiovascular Systems, Inc. Delivery systems for embolic filter devices
EP1337198B1 (fr) * 2000-10-31 2009-06-03 Boston Scientific Limited Dispositif endoluminal combine auto-extensible a extension par ballonnet
US6893451B2 (en) 2000-11-09 2005-05-17 Advanced Cardiovascular Systems, Inc. Apparatus for capturing objects beyond an operative site utilizing a capture device delivered on a medical guide wire
US8372139B2 (en) 2001-02-14 2013-02-12 Advanced Bio Prosthetic Surfaces, Ltd. In vivo sensor and method of making same
US6506203B1 (en) 2000-12-19 2003-01-14 Advanced Cardiovascular Systems, Inc. Low profile sheathless embolic protection system
US6585753B2 (en) 2001-03-28 2003-07-01 Scimed Life Systems, Inc. Expandable coil stent
WO2005074367A2 (fr) 2004-02-03 2005-08-18 Atria Medical Inc. Dispositif et procede de controle de la pression in vivo
WO2002087473A1 (fr) * 2001-04-26 2002-11-07 Vascular Innovation, Inc. Dispositif endoluminal et procede de fabrication dudit dispositif
US7338510B2 (en) 2001-06-29 2008-03-04 Advanced Cardiovascular Systems, Inc. Variable thickness embolic filtering devices and method of manufacturing the same
US6599307B1 (en) 2001-06-29 2003-07-29 Advanced Cardiovascular Systems, Inc. Filter device for embolic protection systems
US6638294B1 (en) 2001-08-30 2003-10-28 Advanced Cardiovascular Systems, Inc. Self furling umbrella frame for carotid filter
US6592606B2 (en) 2001-08-31 2003-07-15 Advanced Cardiovascular Systems, Inc. Hinged short cage for an embolic protection device
SG108867A1 (en) 2001-09-06 2005-02-28 Medinol Ltd Self articulating stent
US8262689B2 (en) 2001-09-28 2012-09-11 Advanced Cardiovascular Systems, Inc. Embolic filtering devices
ATE380001T1 (de) * 2001-10-22 2007-12-15 Terumo Corp Stent und verfahren zu dessen herstellung
US6945994B2 (en) 2001-12-05 2005-09-20 Boston Scientific Scimed, Inc. Combined balloon-expanding and self-expanding stent
AU2002360765C1 (en) 2001-12-20 2009-06-11 Trivascular, Inc. Advanced endovascular graft
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US7241304B2 (en) 2001-12-21 2007-07-10 Advanced Cardiovascular Systems, Inc. Flexible and conformable embolic filtering devices
US7144420B2 (en) 2002-03-14 2006-12-05 Boston Scientific Scimed, Inc. Segmented spine
WO2003082076A2 (fr) 2002-03-25 2003-10-09 Nmt Medical, Inc. Pinces de fermeture de foramen ovale persistant (pfo)
US20030187495A1 (en) * 2002-04-01 2003-10-02 Cully Edward H. Endoluminal devices, embolic filters, methods of manufacture and use
US6908467B2 (en) * 2002-05-14 2005-06-21 The University Of Hong Kong Supreme distracter
EP1509144A4 (fr) 2002-06-03 2008-09-03 Nmt Medical Inc Dispositif a armature de tissu biologique pour l'obturation de defauts intracardiaques
WO2003103476A2 (fr) 2002-06-05 2003-12-18 Nmt Medical, Inc. Dispositif de fermeture du foramen ovale permeable (fop) avec support radial et circonferentiel
US6887258B2 (en) 2002-06-26 2005-05-03 Advanced Cardiovascular Systems, Inc. Embolic filtering devices for bifurcated vessels
US7172614B2 (en) 2002-06-27 2007-02-06 Advanced Cardiovascular Systems, Inc. Support structures for embolic filtering devices
GB2393657A (en) * 2002-08-02 2004-04-07 Rudy Hengelmolen Auxetic tubular liners
US7252675B2 (en) 2002-09-30 2007-08-07 Advanced Cardiovascular, Inc. Embolic filtering devices
US7331973B2 (en) 2002-09-30 2008-02-19 Avdanced Cardiovascular Systems, Inc. Guide wire with embolic filtering attachment
US7976936B2 (en) 2002-10-11 2011-07-12 University Of Connecticut Endoprostheses
US7794494B2 (en) 2002-10-11 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices
US7731744B1 (en) * 2002-10-25 2010-06-08 Advanced Cariovascular Systems, Inc. Intravascular stent for treating vulnerable plaque and method of use
US20040088000A1 (en) 2002-10-31 2004-05-06 Muller Paul F. Single-wire expandable cages for embolic filtering devices
EP1562653A1 (fr) * 2002-11-06 2005-08-17 NMT Medical, Inc. Dispositifs medicaux utilisant un alliage a memoire de forme modifie
US6923829B2 (en) 2002-11-25 2005-08-02 Advanced Bio Prosthetic Surfaces, Ltd. Implantable expandable medical devices having regions of differential mechanical properties and methods of making same
EP1572003B1 (fr) 2002-12-09 2017-03-08 W.L. Gore & Associates, Inc. Dispositifs de fermeture de septum
US7172624B2 (en) 2003-02-06 2007-02-06 Boston Scientific Scimed, Inc. Medical device with magnetic resonance visibility enhancing structure
US7025779B2 (en) * 2003-02-26 2006-04-11 Scimed Life Systems, Inc. Endoluminal device having enhanced affixation characteristics
US8591540B2 (en) 2003-02-27 2013-11-26 Abbott Cardiovascular Systems Inc. Embolic filtering devices
US7163550B2 (en) 2003-03-26 2007-01-16 Scimed Life Systems, Inc. Method for manufacturing medical devices from linear elastic materials while maintaining linear elastic properties
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
ES2436596T3 (es) 2003-07-14 2014-01-03 W.L. Gore & Associates, Inc. Dispositivo tubular de cierre de foramen oval permeable (FOP) con sistema de retención
US7479157B2 (en) 2003-08-07 2009-01-20 Boston Scientific Scimed, Inc. Stent designs which enable the visibility of the inside of the stent during MRI
US7455737B2 (en) * 2003-08-25 2008-11-25 Boston Scientific Scimed, Inc. Selective treatment of linear elastic materials to produce localized areas of superelasticity
US7419498B2 (en) 2003-10-21 2008-09-02 Nmt Medical, Inc. Quick release knot attachment system
WO2005044361A1 (fr) 2003-11-07 2005-05-19 Merlin Md Pte Ltd Dispositifs medicaux implantables a visibilite, proprietes mecaniques et biocompatibilite ameliorees
US7892251B1 (en) 2003-11-12 2011-02-22 Advanced Cardiovascular Systems, Inc. Component for delivering and locking a medical device to a guide wire
US20050149168A1 (en) * 2003-12-30 2005-07-07 Daniel Gregorich Stent to be deployed on a bend
WO2005092203A1 (fr) 2004-03-03 2005-10-06 Nmt Medical, Inc. Systeme d'alimentation/recuperation pour occluseur septal
JP4351560B2 (ja) * 2004-03-05 2009-10-28 Necトーキン株式会社 バルーン拡張超弾性ステント
US7678129B1 (en) 2004-03-19 2010-03-16 Advanced Cardiovascular Systems, Inc. Locking component for an embolic filter assembly
US8715340B2 (en) 2004-03-31 2014-05-06 Merlin Md Pte Ltd. Endovascular device with membrane
US8500751B2 (en) 2004-03-31 2013-08-06 Merlin Md Pte Ltd Medical device
US8915952B2 (en) 2004-03-31 2014-12-23 Merlin Md Pte Ltd. Method for treating aneurysms
DE602004007630T2 (de) * 2004-05-25 2008-06-05 William Cook Europe Aps Stent und Stentbeseitigungsvorrichtung
US8062033B2 (en) 2004-06-08 2011-11-22 Gold Standard Instruments, LLC Dental and medical instruments comprising titanium
US20050278017A1 (en) 2004-06-09 2005-12-15 Scimed Life Systems, Inc. Overlapped stents for scaffolding, flexibility and MRI compatibility
WO2007001392A2 (fr) * 2004-10-01 2007-01-04 The Regents Of The University Of Michigan Fabrication de structures et de materiaux cellulaires en alliage a memoire de forme par assemblage reactif en phase liquide transitoire
US7344560B2 (en) 2004-10-08 2008-03-18 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US8043361B2 (en) 2004-12-10 2011-10-25 Boston Scientific Scimed, Inc. Implantable medical devices, and methods of delivering the same
US8435280B2 (en) * 2005-03-31 2013-05-07 Boston Scientific Scimed, Inc. Flexible stent with variable width elements
US9259305B2 (en) 2005-03-31 2016-02-16 Abbott Cardiovascular Systems Inc. Guide wire locking mechanism for rapid exchange and other catheter systems
US7803180B2 (en) 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
JP5143342B2 (ja) * 2005-05-23 2013-02-13 Necトーキン株式会社 自律機能性ステント
JP4737518B2 (ja) * 2005-05-23 2011-08-03 Necトーキン株式会社 Ti−Ni−Nb合金素子
US7627382B2 (en) * 2005-05-25 2009-12-01 Lake Region Manufacturing, Inc. Medical devices with aromatic polyimide coating
US8292946B2 (en) * 2005-10-25 2012-10-23 Boston Scientific Scimed, Inc. Medical implants with limited resistance to migration
US9681948B2 (en) 2006-01-23 2017-06-20 V-Wave Ltd. Heart anchor device
US8348991B2 (en) 2006-03-29 2013-01-08 Boston Scientific Scimed, Inc. Stent with overlap and high expansion
WO2007147156A1 (fr) * 2006-06-16 2007-12-21 Ev3, Inc. implant À haute rÉsistance À la fatigue, systÈme de placement et procÉdÉ pour son utilisation
US8728010B2 (en) * 2006-08-24 2014-05-20 Boston Scientific Scimed, Inc. Elongate medical device including deformable distal end
US7780798B2 (en) 2006-10-13 2010-08-24 Boston Scientific Scimed, Inc. Medical devices including hardened alloys
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
WO2008131167A1 (fr) 2007-04-18 2008-10-30 Nmt Medical, Inc. Système souple de cathéter
US8211162B2 (en) * 2007-05-25 2012-07-03 Boston Scientific Scimed, Inc. Connector node for durable stent
US8216209B2 (en) 2007-05-31 2012-07-10 Abbott Cardiovascular Systems Inc. Method and apparatus for delivering an agent to a kidney
US7867273B2 (en) 2007-06-27 2011-01-11 Abbott Laboratories Endoprostheses for peripheral arteries and other body vessels
US7988723B2 (en) 2007-08-02 2011-08-02 Flexible Stenting Solutions, Inc. Flexible stent
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
DE102007050666A1 (de) * 2007-10-24 2009-04-30 Biotronik Vi Patent Ag Stent aus Nitinol mit verbesserter axialer Biegesteifigkeit und dazugehöriges Herstellungsverfahren
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US8262692B2 (en) 2008-09-05 2012-09-11 Merlin Md Pte Ltd Endovascular device
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
GB2468861B (en) * 2009-03-23 2011-05-18 Cook William Europ Conformable stent structure and method of making same
EP2427143B1 (fr) 2009-05-04 2017-08-02 V-Wave Ltd. Dispositif permettant de réguler la pression à l'intérieur d'une cavité cardiaque
US9034034B2 (en) 2010-12-22 2015-05-19 V-Wave Ltd. Devices for reducing left atrial pressure, and methods of making and using same
US12453626B2 (en) 2009-05-04 2025-10-28 V-Wave Ltd. Shunt for redistributing atrial blood volume
US12186176B2 (en) 2009-05-04 2025-01-07 V-Wave Ltd. Shunt for redistributing atrial blood volume
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US9636094B2 (en) 2009-06-22 2017-05-02 W. L. Gore & Associates, Inc. Sealing device and delivery system
US20110022026A1 (en) 2009-07-21 2011-01-27 Lake Region Manufacturing, Inc. d/b/a Lake Region Medical. Inc. Methods and Devices for Delivering Drugs Using Drug-Delivery or Drug-Coated Guidewires
EP2461900A4 (fr) 2009-08-07 2017-08-02 Innovative Processing Technologies Inc. Procédés et systèmes de traitement de matériaux, y compris des matériaux à mémoire de forme
GB2476479B (en) * 2009-12-22 2012-06-20 Cook Medical Technologies Llc Implantable device
WO2011082227A1 (fr) * 2009-12-29 2011-07-07 Boston Scientific Scimed, Inc. Conception de stent à faible pression d'ouverture et à résistance élevée
US8382834B2 (en) 2010-04-12 2013-02-26 Enteroptyx Induction heater system for shape memory medical implants and method of activating shape memory medical implants within the mammalian body
US20120209338A1 (en) 2011-02-10 2012-08-16 Jorge Groiso Device for correction of bone and soft tissue disorders
EP3031428B1 (fr) 2011-03-08 2020-11-18 W.L. Gore & Associates, Inc Dispositif médical destiné à être utilisé avec une stomie
US11135054B2 (en) 2011-07-28 2021-10-05 V-Wave Ltd. Interatrial shunts having biodegradable material, and methods of making and using same
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
FR2981260B1 (fr) 2011-10-18 2014-12-12 Univ Grenoble 1 Dispositif de guidage d'une aiguille medicale
EP2790598B1 (fr) * 2011-12-16 2017-04-26 Stryker Corporation Cage d'embolectomie
US8894701B2 (en) 2011-12-23 2014-11-25 Cook Medical Technologies Llc Hybrid balloon-expandable/self-expanding prosthesis for deployment in a body vessel and method of making
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
JP6324371B2 (ja) 2012-04-06 2018-05-16 マーリン エムディー プライベート リミテッド 動脈瘤を治療するためのデバイスおよび方法
US9439712B2 (en) 2012-07-12 2016-09-13 Covidien Lp Heat-distribution indicators, thermal zone indicators, electrosurgical systems including same and methods of directing energy to tissue using same
US20140018793A1 (en) * 2012-07-12 2014-01-16 Covidien Lp Heat-distribution indicators, thermal zone indicators, electrosurgical systems including same and methods of directing energy to tissue using same
US20140094861A1 (en) * 2012-10-01 2014-04-03 Smith & Nephew, Inc. Surgical locator
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
US9713696B2 (en) 2013-05-21 2017-07-25 V-Wave Ltd. Apparatus and methods for delivering devices for reducing left atrial pressure
EP2915505B1 (fr) * 2014-03-07 2018-01-10 Novus Scientific AB Dispositif de support utilisé dans la reconstruction médicale du sein
US10004509B2 (en) 2014-05-02 2018-06-26 W. L. Gore & Associates, Inc. Anastomosis devices
US11439396B2 (en) 2014-05-02 2022-09-13 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11712230B2 (en) 2014-05-02 2023-08-01 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
WO2016178171A1 (fr) 2015-05-07 2016-11-10 The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center Shunts interauriculaires temporaires
WO2016182791A1 (fr) 2015-05-14 2016-11-17 Cook Medical Technologies, LLC Stylet à aiguille endoscopique à longueurs de flexibilité améliorée
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US20170340460A1 (en) 2016-05-31 2017-11-30 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US10835394B2 (en) 2016-05-31 2020-11-17 V-Wave, Ltd. Systems and methods for making encapsulated hourglass shaped stents
US10932685B2 (en) * 2017-01-09 2021-03-02 Biosense Webster (Israel) Ltd. Catheter with supporting structure having variable dimensions
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
EP3589238A1 (fr) 2017-03-03 2020-01-08 V-Wave Ltd. Dérivation de redistribution du volume sanguin atrial
US11724075B2 (en) 2017-04-18 2023-08-15 W. L. Gore & Associates, Inc. Deployment constraining sheath that enables staged deployment by device section
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US10898698B1 (en) * 2020-05-04 2021-01-26 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
EP3740163A1 (fr) 2018-01-20 2020-11-25 V-Wave Ltd. Dispositifs et procédés pour fournir un passage entre des chambres cardiaques
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
WO2019188689A1 (fr) * 2018-03-27 2019-10-03 テルモ株式会社 Stent
US11291570B2 (en) 2018-04-27 2022-04-05 Cook Medical Technologies Llc Hybrid stent and delivery system
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
US12226602B2 (en) 2019-04-03 2025-02-18 V-Wave Ltd. Systems for delivering implantable devices across an atrial septum
WO2020234751A1 (fr) 2019-05-20 2020-11-26 V-Wave Ltd. Systèmes et procédés de création de dérivation interauriculaire
US12599756B2 (en) 2020-05-04 2026-04-14 V-Wave Ltd. Devices with dimensions that can be reduced and increased In Vivo
US11234702B1 (en) 2020-11-13 2022-02-01 V-Wave Ltd. Interatrial shunt having physiologic sensor
AU2023252664A1 (en) 2022-04-14 2024-10-17 V-Wave Ltd. Interatrial shunt with expanded neck region
AU2024363044A1 (en) 2023-10-18 2026-04-16 V-Wave Ltd. Hybrid devices with dimensions that can be adjusted in vivo and methods of manufacturing thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3012332A (en) * 1959-04-16 1961-12-12 Gen Electric Heat storage reservoir for clothes dryer
US3012882A (en) 1960-01-26 1961-12-12 Muldawer Leonard Temperature responsive cadmium-silver-gold alloys
US3174851A (en) 1961-12-01 1965-03-23 William J Buehler Nickel-base alloys
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US5171383A (en) 1987-01-07 1992-12-15 Terumo Kabushiki Kaisha Method of manufacturing a differentially heat treated catheter guide wire
DE69007841T2 (de) 1989-04-28 1994-08-11 Terumo Corp Schnell betriebsbereiter Führungsdraht für Katheter unter Anwendung einer Memory-Legierung mit Pseudoelastizität.
CA2026604A1 (fr) 1989-10-02 1991-04-03 Rodney G. Wolff Drain articule
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
FR2683449A1 (fr) * 1991-11-08 1993-05-14 Cardon Alain Endoprothese pour implantation transluminale.
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5769796A (en) 1993-05-11 1998-06-23 Target Therapeutics, Inc. Super-elastic composite guidewire
EP0746236B1 (fr) 1993-10-01 2003-08-20 Boston Scientific Corporation Filtre ameliore pour veine cave
JP4046760B2 (ja) 1994-05-19 2008-02-13 ボストン サイエンティフィック サイムド, インコーポレイテッド 改良型組織支持装置
US5709704A (en) 1994-11-30 1998-01-20 Boston Scientific Corporation Blood clot filtering
US5776100A (en) * 1995-09-27 1998-07-07 Interventional Innovations Corporation Nickel titanium guide wires for occlusion and drug delivery
US5836893A (en) 1996-03-08 1998-11-17 Scimed Life Systems, Inc. Intravascular guidewire
US5868780A (en) 1996-03-22 1999-02-09 Lashinski; Robert D. Stents for supporting lumens in living tissue
US5931819A (en) 1996-04-18 1999-08-03 Advanced Cardiovascular Systems, Inc. Guidewire with a variable stiffness distal portion
US6068623A (en) * 1997-03-06 2000-05-30 Percusurge, Inc. Hollow medical wires and methods of constructing same
US5843244A (en) 1996-06-13 1998-12-01 Nitinol Devices And Components Shape memory alloy treatment
DE19633901A1 (de) 1996-08-22 1998-02-26 Thomas Prof Dr Med Ischinger Gefäßstütze in Form einer Schlauchabschnitts-artigen Stützstruktur
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5846247A (en) 1996-11-15 1998-12-08 Unsworth; John D. Shape memory tubular deployment system
US5924998A (en) 1997-03-06 1999-07-20 Scimed Life System, Inc. Guide wire with hydrophilically coated tip
US5853419A (en) * 1997-03-17 1998-12-29 Surface Genesis, Inc. Stent
US5868783A (en) * 1997-04-16 1999-02-09 Numed, Inc. Intravascular stent with limited axial shrinkage
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6425855B2 (en) * 1999-04-06 2002-07-30 Cordis Corporation Method for making a multi-laminate stent having superelastic articulated sections
US6485507B1 (en) 1999-07-28 2002-11-26 Scimed Life Systems Multi-property nitinol by heat treatment
US6585753B2 (en) * 2001-03-28 2003-07-01 Scimed Life Systems, Inc. Expandable coil stent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0108600A2 *

Also Published As

Publication number Publication date
JP2003505194A (ja) 2003-02-12
CA2378920C (fr) 2009-01-13
ATE342699T1 (de) 2006-11-15
CA2378920A1 (fr) 2001-02-08
AU5630900A (en) 2001-02-19
US6997947B2 (en) 2006-02-14
US6485507B1 (en) 2002-11-26
IL147727A0 (en) 2002-08-14
EP1200014B1 (fr) 2006-10-18
WO2001008600A2 (fr) 2001-02-08
WO2001008600A3 (fr) 2001-07-05
DE60031413D1 (de) 2006-11-30
US20030109918A1 (en) 2003-06-12
US20060100693A1 (en) 2006-05-11
DE60031413T2 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
CA2378920C (fr) Nitinol a proprietes multiples obtenu par traitement thermique
US7632303B1 (en) Variable stiffness medical devices
EP0759730B1 (fr) Dispositifs de soutien de tissus ameliores
JP3519120B2 (ja) 内腔拡張器
EP1656965B1 (fr) Système de fil de guidage pour occlusion totale
AU2002256376B2 (en) Endoluminal device and method for fabricating same
US20070239259A1 (en) Nitinol alloy design and composition for medical devices
US20110152994A1 (en) Implantable device
US6440162B1 (en) Stent having increased scaffolding expandable bar arms
EP2410956B1 (fr) Structure d'endoprothèse conformable et procédé de réalisation de celle-ci
US20050059994A1 (en) Fatigue resistant medical devices
EP1479358A1 (fr) Dispositif intraluminal à radio-opacité améliorée
US20110040371A1 (en) Coiled assembly for supporting the wall of a lumen
JP2004501680A (ja) 剛性に差異を設けたステント
AU2002256376A1 (en) Endoluminal device and method for fabricating same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20050111

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRE;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.SCRIBED TIME-LIMIT

Effective date: 20061018

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061018

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061018

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061018

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061018

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60031413

Country of ref document: DE

Date of ref document: 20061130

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070118

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070319

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

EN Fr: translation not filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070630

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20070622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070119

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061018

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070622

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20100630

Year of fee payment: 11

BERE Be: lapsed

Owner name: BOSTON SCIENTIFIC LIMITED

Effective date: 20110630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110630

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20120614

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20130611

Year of fee payment: 14

Ref country code: DE

Payment date: 20130619

Year of fee payment: 14

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20140101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140101

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60031413

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60031413

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60031413

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60031413

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

Effective date: 20150202

Ref country code: DE

Ref legal event code: R082

Ref document number: 60031413

Country of ref document: DE

Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE

Effective date: 20140930

Ref country code: DE

Ref legal event code: R081

Ref document number: 60031413

Country of ref document: DE

Owner name: BOSTON SCIENTIFIC LIMITED, BM

Free format text: FORMER OWNER: BOSTON SCIENTIFIC LTD., ST. MICHAEL, BARBADOS, BB

Effective date: 20150202

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60031413

Country of ref document: DE

Effective date: 20150101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150101

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140622